Bearish flow noted in Summit Therapeutics (SMMT) with 5,713 puts trading, or 14x expected. Most active are Jul-26 20 puts and Jun-26 23 puts, with total volume in those strikes near 5,200 contracts. The Put/Call Ratio is 11.11, while ATM IV is up nearly 4 points on the day. Earnings are expected on April 30th.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMMT:
- Summit partner selection for ASCO plenary signals strong OS, says Leerink
- Summit partner selection for ASCO ‘likely a major positive,’ says Guggenheim
- Biotech Alert: Searches spiking for these stocks today
- Positioning Ivonescimab to Anchor a ~$200B PD-1xVEGF Market: Early NSCLC Validation and Commercial Head Start Support Buy Rating on Summit
- Summit Therapeutics initiated with a Buy at Stifel